Log In
Print this Print this

Cordaptive, Pelzont, Tredaptive, Trevaclyn (MK-0524A)

Also known as: ER niacin/laropiprant

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionCombination of laropiprant, a selective inhibitor of prostaglandin D2 (PGD2) receptor subtype DP1 (PTGDR1;DP1), and extended-release niacin
Molecular Target Prostaglandin D2 (PGD2) receptor subtype DP1 (PTGDR1) (DP1)
Mechanism of ActionProstaglandin D2 (PGD2) receptor subtype DP2 (CRTH2) antagonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today